'The EMVision fusion classification was observed to demonstrate an ability to differentiate between haemorrhagic and ischaemic stroke with an overall accuracy of 98% in the full sample (50)'.
So 1 out of the 50 was not identified accurately. Sounds pretty good to me. With the AI on board, it will be great to see the classification get even more accurate over time.
Well done team!
Ann: Clinical Trial Data Drives Confidence for Expanded Studies, page-2
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.03 |
Change
0.080(4.10%) |
Mkt cap ! $173.4M | |||
| Open | High | Low | Value | Volume |
| $1.98 | $2.03 | $1.97 | $65.64K | 33.17K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15452 | $1.98 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.03 | 3999 | 1 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| EMV (ASX) Chart |